Beneficial effects of training at the anaerobic threshold in addition to pharmacotherapy on weight loss, body composition, and exercise performance in women with obesity

Figures & data

Figure 1 The mean (± SE) values for the patients’ FM/BW at the beginning of the study (basal) and after 4 weeks, 8 weeks, and 12 weeks.

Notes: (A) Orlistat–exercise group; and (B) the orlistat group. *Significant compared to the basal level.
Abbreviations: FM/BW, fat mass to body weight ratio; NS, not significant; SE, standard error.

Figure 2 The mean (± SE) values for the patients’ FFM/BW at the beginning of the study (week 0) and after 4 weeks, 8 weeks, and 12 weeks for the orlistat–exercise group (black) and the orlistat group (white).

Notes: (A) Orlistat–exercise group; (B) orlistat group. *Significant compared to the basal level.
Abbreviations: FFM/BW, fat-free mass to body weight ratio; NS, not significant; SE, standard error.

Table 1 The mean (± SE) values for BMI, body weight, fat mass, FFM, Wmax, work rate at the AT at the beginning of the study (basal), at 4 weeks, at 8 weeks, and at the end of the treatment period with orlistat and orlistat plus exercise

	Orlistat (n=14)				Orlistat–exercise (n =14)
	Basal	4 weeks	8 weeks	12 weeks	Basal	4 weeks	8 weeks	12 weeks
BMI (kg/m^2)	37.5±0.9	36.2±0.8*	35.5±0.8*	34.5±0.8*	38.6±1.2	37.0±1.3*	35.7±1.2*	34.5±1.2*
Weight (kg)	91.6±2.7	88.3±2.5*	86.6±2.4*	84.1±2.4*	94.7±3.1	90.7±3.3*	87.5±3.2*	84.6±3.3*
Fat mass (kg)	40.3±1.6	38.4±1.6*	37.1±1.4*	35.5±1.5*	42.9±2.4	39.3±2.4*	36.2±2.4*	34.7±2.7*
FFM (kg)	51.6±1.6	49.9±1.0*	49.5±1.1*	49.3±1.4*	51.8±1.0	51.6±1.3^NS	51.2±1.1^NS	50.0±0.8*
Wmax (W)	87.8±3	90.7±4^NS	97.1±4*	105.0±4*	92.1±3	126.7±3*	134.2±4*	135.0±4*
AT (W)	55.0±2	57.8±2*	59.6±3*	68.5±2*	57.8±2	84.2±2*	91.7±2*	92.1±3*

Note:

* Significant compared to the basal level.

Abbreviations: SE, standard error; BMI, body mass index; FFM, fat-free mass; Wmax, maximal exercise capacity; AT, anabolic threshold; n, number; NS, not significant compared to basal level; W, watts.

Figure 3 The mean (± SE) values for the patients’ Wmax/BW (W/kg) at the beginning of the study (basal) and after 4 weeks, 8 weeks, and 12 weeks for the orlistat group (white) and the orlistat–exercise group (black).

Note: *Significant compared to the basal level.
Abbreviations: Wmax/BW, maximal exercise capacity with regards to total body weight; SE, standard error; W, watts.